Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

160324-f-hc995-002

Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children

February 18, 2020 Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland

The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …
News

Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration

February 18, 2020 Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma

The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
News
merck-keytruda-pembrolizumab-melanoma

NICE gives initial ‘no’ to NHS England for kidney cancer drug

February 18, 2020 Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda

The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …
News
syringe-and-hypodermic-needles

Rapid testing to help combat worst UK outbreak of HIV in 30 years

February 18, 2020 Manufacturing and Production AIDS, HIV, HIV England, HIV Scotland, HIV epidemic, HIV/AIDS

New HIV tests that provide results in minutes are being used in Glasgow to fight a recent outbreak of HIV. …
News

Patient Experience: Living with multiple rare diseases

February 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma, rare disease

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her life, and …
Feature
top_10_image_2_1_0

Top Ten most popular articles on Pharmafile.com this week

February 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Chinese Coronavirus, Wuhan, Wuhan Coronavirus, china coronavirus, coronavirus

The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …
News

Sanofi axes four major players from its executive committee

February 13, 2020 Manufacturing and Production, Medical Communications Sanofi, appointments, pharma

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …
News
48023051583_a1d0580cea_b

How do the Presidential frontrunners plan to combat the opioid crisis?

February 12, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Election, Bernie, Bernie Sanders, Donald Trump, Joe, Joe Biden, Trump

The widespread addiction to extremely potent, legal painkillers has decimated the lives of millions across the United States. Overdoses from …
Feature
andrea_pfeifer_edit

Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune

February 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …
Feature
lilly_building_with_american_flag_web

Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease

February 11, 2020 Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure

In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …
News
five-clear-glass-vial-bottles

Scotland approves targetted combination therapy for advanced melanoma

February 11, 2020 Manufacturing and Production NHS, SMC, Scotland, UK, advanced melanoma, melanoma

The Scottish Medicines Consortium (SMC) has approved targeted combination therapy for the treatment of adult patient with unresectable or metastatic …
News
type_2_diabetes_28081593711

Type 2 diabetes cases up 40% in Scotland

February 11, 2020 Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes

According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years. …
News
libtayo

Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma

February 11, 2020 Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma

Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …
News
flu_shot_2019

Patient successfully treated for coronavirus in the US

February 11, 2020 Manufacturing and Production Chinese Coronavirus, Coronavirus Wuhan, Ebola, Wuhan Coronavirus, coronavirus

Health officials in the US say they have successfully treated a man for coronavirus with an experimental drug. The Ebola …
News
1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026